NM_006767.4:c.1397G>A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PS3PM1PM5PP3_ModeratePP5_Very_Strong
The NM_006767.4(LZTR1):c.1397G>A(p.Arg466Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,612,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV001437345: Publications also reported experimental evidence, and demonstrated that the variant increased Ras signaling, and resulted in impaired subcellular location (Steklov_2018, Bigenzahn_2018).; SCV001503248: Experimental studies have shown that this missense change affects LZTR1 function (PMID:30442762).; SCV004564302: Consistent with predictions, functional studies suggest the variant protein has altered cellular localization, reduced interaction with the binding partner protein CUL3, and is associated with elevated levels of Ras signaling (Bigenzahn 2018, Steklov 2018). PMID:30442766. PMID:30442762.; SCV002701699: One functional study suggested that this alteration may impair complex formation with CUL3 and cellular localization (Steklov M et al. Science, 2018 12;362:1177-1182).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R466L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006767.4 missense
Scores
Clinical Significance
Conservation
Publications
- LZTR1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Noonan syndrome 10Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- schwannomatosisInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Noonan syndromeInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
- breast cancerInheritance: AD Classification: MODERATE Submitted by: G2P
- Costello syndromeInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome with multiple lentiginesInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- cardiofaciocutaneous syndromeInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome-like disorder with loose anagen hairInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006767.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LZTR1 | MANE Select | c.1397G>A | p.Arg466Gln | missense | Exon 13 of 21 | ENSP00000496779.1 | Q8N653 | ||
| LZTR1 | c.1397G>A | p.Arg466Gln | missense | Exon 13 of 21 | ENSP00000558088.1 | ||||
| LZTR1 | c.1394G>A | p.Arg465Gln | missense | Exon 13 of 21 | ENSP00000558091.1 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152240Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000323 AC: 8AN: 247306 AF XY: 0.0000298 show subpopulations
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1460350Hom.: 0 Cov.: 34 AF XY: 0.0000330 AC XY: 24AN XY: 726432 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152240Hom.: 0 Cov.: 34 AF XY: 0.0000807 AC XY: 6AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at